Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930413-10-003752
Filing Date
2010-07-01
Accepted
2010-07-01 11:27:10
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 c62001_10ka.htm 10-K/A 398962
2 GRAPHIC c62001001_v1.jpg GRAPHIC 12379
3 c62001_ex23.htm EX-23 1526
4 c62001_ex31-1.htm EX-31.1 3035
5 c62001_ex31-2.htm EX-31.2 3454
  Complete submission text file 0000930413-10-003752.txt   425919
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-12957 | Film No.: 10929414
SIC: 2836 Biological Products, (No Diagnostic Substances)